School of Medicine

A large-scale study that analyzed genetics and smoking habits has revealed new information about blood pressure. The study, conducted by an international consortium of investigators, was led by School of Medicine researchers.

A series of posters highlighting notable African-Americans in science and technology is on display in the Farrell Learning and Teaching Center (FLTC) Atrium on the Washington University Medical Campus through Feb. 28. The traveling poster series then can be seen in Seigle Hall on the Danforth Campus from March 5-29; and again at the FLTC Atrium from Aug. 1-31.

Through research in mice, School of Medicine scientists have exploited cancer cell metabolism to kill cervical tumors that are resistant to standard chemotherapy and radiation.

An international team of scientists, led by McDonnell Genome Institute at the School of Medicine, has sequenced the genome of the Amazon molly, a fish that reproduces asexually. The researchers expected that the asexual organism would be at a genetic disadvantage, but the Amazon molly is thriving.

Aimee James, associate professor of surgery in the Division of Public Health Sciences at Washington University School of Medicine in St. Louis, has been appointed the Prevention and Control Research Program co-leader for Siteman Cancer Center. 

The university’s Office of Technology Management is organizing the Women in Innovation and Technology symposium later this month. The event is one way the office is helping to educate, train and guide women through the commercialization process.

Two faculty members, Vijay Ramani, of the School of Engineering & Applied Science, and Jennifer Silva, MD, of the School of Medicine, were named inaugural faculty fellows in entrepreneurship at Washington University in St. Louis.

Fourteen planners and project managers within the Operations and Facilities Management Department (OFMD) at Washington University School of Medicine in St. Louis recently completed Mini-Medical School I.

Scientists at the School of Medicine have transformed skin cells from patients with Huntington’s disease into the type of brain cell affected by the disorder. This offers a new tool to study the degenerative and eventually fatal neurological condition.

John DiPersio, MD, PhD, director of the Division of Oncology and deputy director of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, has been elected to the top leadership post in the American Society for Blood and Marrow Transplantation. He will take over the role during the society’s meetings in Salt Lake City later in February.